Focused Issue on Gallbladder Cancer

Posted On 2019-06-22 16:51:22


This focused issue on “Gallbladder Cancer” is edited by Dr. Ghassan Abou-Alfa, from Memorial Sloan-Kettering Cancer Center, Weill Medical College at Cornell University, New York, USA.

Dr. Abou-Alfa’s research is dedicated to finding novel therapies and improving the effectiveness current therapies for hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer, while continuing to understand the basic mechanisms of the disease and its therapies. Dr. Abou-Alfa has many publications in the field of hepatocellular carcinoma. He led on many occasions, international teams of investigators, and published the first report on the effective role of the novel agent sorafenib in the treatment of primary liver cancer.

Focused issue outline:

  1. Preface to This Focused Issue
    Ghassan Abou-Alfa, Memorial Sloan-Kettering Cancer Center, Weill Medical College at Cornell University, New York, USA
  2. Epidemiology and GWAS
    Lewis Roberts, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
  3. Epidemiology of Gallbladder Cancer in India
    Vinay Kapoor, Usha V Dutta, Department of Surgical Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
  4. Management of Gallbladder Cancer in India
    Mahesh Goel, GI & HPB Service, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
  5. Gallbladder Cancer in Chile
     Justo Lorenzo, Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany
  6. South America Experience
    Gerardo Arroyo, Department of Citohistología, Universidad de San Carlos de Guatemala , Guatemala, Guatemala
  7. US Gallbladder Experience Among Indian Nations
    Yehuda Patt, University of New Mexico, Albuquerque, New Mexico, USA
  8. Pathology
    Ghazi Zaatari, Environment Core Laboratory, Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut Medical Center, American University of Beirut, Beirut, Lebanon
  9. Mutational Changes in Biliary Cancer
    Sebastian Mondaca, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA
  10. Incidental Gallbladder
    Shishir Maithel, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA
  11. Surgical Intervention
    Alice C Wei, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  12. Adjuvant Therapy
    John Bridgewater, UCL Cancer Institute, London, UK
  13. Systemic Chemotherapy
    Juan W Valle, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
  14. Systemic Targeted Therapy
    Milind Javle, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  15. Radiation Therapy
    Christopher Crane, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, NY, USA
  16. Interventional Radiology
    David Madoff, Department of Radiology, Division of Interventional Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA